Beleaguered Sage Snapped Up In Deal Worth Up To $561 Million

Why did Metaplanet's Bitcoin holdings surge? How is the Israel-Iran conflict impacting oil prices? What caused Uber and unions to settle driver wage dispute? Why is Trump launching a mobile phone company? How did Trump's approval affect U.S. Steel's stock? What explains AMD's recent stock rally? Why are WhatsApp ads now rolling out?

Beleaguered Sage Snapped Up In Deal Worth Up To $561 Million

investors.com/news/technology/sage-therapeutics-takeover-supernus-pharmaceuticals/?src=A00220

Supernus Pharmaceuticals (SUPN) agreed Monday to buy beleaguered biotech Sage Therapeutics (SAGE) in a deal worth up to $561 million.
The news sent Sage stock flying more than 34% to 9, while Supernus stock rose 3.3% to 33.07.
↑ X How To Buy Stocks: Bases And Buy PointsSupernus Pharma…

This story appeared on investors.com, 2025-06-16 13:14:04.